Private equity firm Clayton, Dubilier & Rice (CDR) has agreed to buy London-listed UDG Healthcare for 2.6 billion pounds ($3.7 billion), the pharmaceuticals services company said on Wednesday.
CDR has agreed to pay 10.23 pounds in cash per share in UDG, a premium of 21.5% on Tuesday’s close.
Read more/Source: Reuters
